UPDATE: New Deal with Incyte Frees OGS to Develop Proteomics Platforms | GenomeWeb

This story has been updated from a previous version.

NEW YORK, Nov 7 -  Incyte and Oxford GlycoSciences said Tuesday they would end the exclusive profit-sharing proteomics deal they began in January 1998 and that future collaboration will occur on a non-exclusive contract basis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.